The generic name for Humalog is insulin lispro, a rapid-acting insulin analog used at mealtimes. Humalog is the brand name sold by Eli Lilly since 1996. Lilly also sells an authorized generic at a lower list price, and Sanofi’s Admelog is a follow-on lispro product approved by the FDA.
What Insulin Lispro Is
Insulin lispro is a human insulin analog made with recombinant DNA technology. The molecule differs from natural human insulin by a reversed sequence of two amino acids (lysine and proline) at the B28 and B29 positions. This small change makes the insulin dissociate into active monomers faster, so it starts working within about 15 minutes after injection.
Per the FDA prescribing information, insulin lispro has an onset of 15 minutes, peak at 30 to 90 minutes, and duration of 3 to 5 hours, making it suitable for covering meal-related glucose rises.
Humalog, Authorized Generic, and Admelog Compared
| Product | Active Ingredient | Manufacturer | Notes |
|---|---|---|---|
| Humalog | Insulin lispro 100 U/mL | Eli Lilly | Original brand; also 200 U/mL concentrated version |
| Insulin Lispro Injection (authorized generic) | Insulin lispro 100 U/mL | Eli Lilly | Identical product, ~50% lower list price |
| Admelog | Insulin lispro 100 U/mL | Sanofi | Follow-on via 505(b)(2); therapeutic equivalence confirmed |
| Lyumjev | Insulin lispro-aabc 100 U/mL | Eli Lilly | Ultra-rapid lispro with added treprostinil and citrate for faster onset |
Are These Considered “Generics” or “Biosimilars”?
In U.S. pharmacy language, true generics are identical small-molecule drugs. Insulin is a large biologic molecule, so products similar to a branded insulin are technically biosimilars or follow-on biologics. That said, Lilly’s authorized generic of Humalog is the same biologic molecule made by the originator, so it is functionally interchangeable.
As of 2020, the FDA transitioned insulin regulation under the biologics pathway, which allowed biosimilar and interchangeable products to enter the market more readily. Admelog was later reviewed under this framework.
How Insulin Lispro Is Used
Insulin lispro is typically injected 0 to 15 minutes before a meal. Common uses include:
- Mealtime (bolus) coverage in basal-bolus therapy for type 1 or type 2 diabetes
- Correction dosing for elevated pre-meal glucose
- Continuous subcutaneous infusion (insulin pumps)
- Intravenous use in hospital settings under supervision
Dosing is individualized using an insulin-to-carbohydrate ratio and correction factor prescribed by your clinician. For general context on diabetes management, review our treatment hub.
Injection Sites and Technique
- Wash hands and inspect the pen or vial for clarity. Insulin lispro should be clear and colorless.
- Choose a site: abdomen (fastest absorption), thigh, upper arm, or buttock.
- Clean the area with alcohol and let it dry.
- Pinch the skin, insert at 90 degrees, and inject.
- Hold the needle in place for 5 to 10 seconds before removing.
- Rotate injection sites within an area to prevent lipohypertrophy.
Side Effects and Precautions
The most common and serious side effect of any insulin, including lispro, is hypoglycemia. Early symptoms include shakiness, sweating, fast heart rate, hunger, and trouble concentrating. Always carry fast-acting glucose.
Other possible adverse effects include:
- Weight gain
- Injection site redness, itching, or lipohypertrophy
- Rare allergic reactions
- Hypokalemia, especially with IV administration
Storage
Unopened insulin lispro is stored at 36 to 46 degrees Fahrenheit. Do not freeze. Once opened and kept at room temperature (below 86 F), pens and vials are stable for 28 days; after that, discard even if liquid remains. Avoid direct sunlight and do not leave insulin in a hot car.
How to Save on Insulin Lispro
The U.S. insulin cost landscape has shifted substantially since 2023. Options to reduce out-of-pocket spending include:
- Medicare beneficiaries: Part D and Part B insulin costs capped at $35 per month per product.
- Commercial insurance: Many plans now cap insulin at $35 per month; Eli Lilly’s Insulin Value Program offers a $35 cap regardless of insurance.
- Switching to the Lilly authorized generic (Insulin Lispro Injection) at about half the Humalog list price.
- Manufacturer patient assistance programs for those who meet income criteria.
- Non-profit programs such as Dispensary of Hope or GoodRx coupons for uninsured patients.
Switching Between Lispro Products
Most patients who switch between Humalog, Lilly’s authorized generic, and Admelog do not need dose changes, but always confirm with your prescriber. Pens and pumps may have compatibility differences; for example, some pumps list specific compatible insulins in their labeling. Never switch products the same day as starting a new insulin pump without guidance.
Ultra-Rapid Alternatives
If post-meal glucose spikes remain problematic despite good dosing, faster insulins may help. Lyumjev (insulin lispro-aabc) and Fiasp (insulin aspart with niacinamide) both start working faster than standard lispro or aspart. For basic concepts on how glucose over time is measured, see our A1C levels guide.
The Bottom Line
The Humalog generic name is insulin lispro, a rapid-acting analog used at meals for diabetes management. Lilly’s authorized generic and Sanofi’s Admelog offer similar products at lower costs, while Lyumjev adds an ultra-rapid profile. Work with your clinician to choose the right product, dose, and delivery device, and take advantage of the $35 insulin copay cap and patient assistance programs where eligible.
